A Rare Case of Symptomatic Pulmonary Infection Caused by Mycobacterium paraffinicum

<i>Mycobacterium paraffinicum</i> <i>(M. paraffinicum)</i> is a non-tuberculous mycobacterium (NTM) shown to be a human pathogen in recent years. Here, we present a rare case of pulmonary infection caused by <i>M. paraffinicum</i> in a 69-year-old female patient who presented with symptoms, initially thought to be from a chronic obstructive pulmonary disease (COPD) exacerbation. From our literature review, this is a case of <i>M. paraffinicum</i> presenting as a human pathogen. The patient's medical history included COPD, obstructive sleep apnea (OSA), and obesity. Her medical management included inhaled corticosteroid (ICS)/ long-acting beta-agonist (LABA), long-acting muscarinic antagonist (LAMA), and nocturnal continuous positive airway pressure (CPAP) device. For her acute worsening of symptoms, she was treated with oral ciprofloxacin and prednisone for possible COPD exacerbation from presumed pneumonia. However, she showed no improvement in her pulmonary symptoms. Follow-up computed tomography (CT) imaging of the chest showed new scattered "Tree in Bud" opacities. Sputum studies and acid-fast bacilli (AFB) cultures revealed the growth of <i>M. paraffinicum.</i> She was treated with a combination of oral clarithromycin, moxifloxacin, and rifabutin. This case highlights the importance of keeping atypical mycobacteria, such as NTM, as a cause of pulmonary infection in the differential diagnosis, particularly in patients with chronic pulmonary conditions who present with persistent and/or unexplained respiratory symptoms. Early identification is crucial for appropriate treatment to improve patient outcomes.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-06-29
DOI
https://doi.org/10.7759/cureus.86982
Primary Topic
Mycobacterium research and diagnosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Rare Case of Symptomatic Pulmonary Infection Caused by Mycobacterium paraffinicum

Nirja Sutaria, Ha Vinh, Arun Adlakha
1 links
Cureus
Mycobacterium research and diagnosis
article

A Rare Case of Symptomatic Pulmonary Infection Caused by Mycobacterium paraffinicum

Nirja Sutaria, Ha Vinh, Arun Adlakha
article en

Abstract

<i>Mycobacterium paraffinicum</i> <i>(M. paraffinicum)</i> is a non-tuberculous mycobacterium (NTM) shown to be a human pathogen in recent years. Here, we present a rare case of pulmonary infection caused by <i>M. paraffinicum</i> in a 69-year-old female patient who presented with symptoms, initially thought to be from a chronic obstructive pulmonary disease (COPD) exacerbation. From our literature review, this is a case of <i>M. paraffinicum</i> presenting as a human pathogen. The patient's medical history included COPD, obstructive sleep apnea (OSA), and obesity. Her medical management included inhaled corticosteroid (ICS)/ long-acting beta-agonist (LABA), long-acting muscarinic antagonist (LAMA), and nocturnal continuous positive airway pressure (CPAP) device. For her acute worsening of symptoms, she was treated with oral ciprofloxacin and prednisone for possible COPD exacerbation from presumed pneumonia. However, she showed no improvement in her pulmonary symptoms. Follow-up computed tomography (CT) imaging of the chest showed new scattered "Tree in Bud" opacities. Sputum studies and acid-fast bacilli (AFB) cultures revealed the growth of <i>M. paraffinicum.</i> She was treated with a combination of oral clarithromycin, moxifloxacin, and rifabutin. This case highlights the importance of keeping atypical mycobacteria, such as NTM, as a cause of pulmonary infection in the differential diagnosis, particularly in patients with chronic pulmonary conditions who present with persistent and/or unexplained respiratory symptoms. Early identification is crucial for appropriate treatment to improve patient outcomes.

CureusVol. 17(6)
Atrium Medical Cente (US), Pulmonary Associates (US), Edward Via College of Osteopathic Medicine (US)
Good health and well-being
Openalex Percentile: Top 78%
Mycobacterium research and diagnosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.